Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AKAP13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EIF2B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAM22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FHL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRAS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPRK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DROSHA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C18orf8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC202181 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
KIF3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SETD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C15orf39 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
P2RX7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM117A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATG2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTCP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LANCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KDELR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNB5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on